<i>Streptomyces griseus</i>
            (Krainsky) Waksman and Henrici

Waksman, Selman A.; Reilly, H. Christine; Harris, Dale A.

doi:10.1128/jb.56.3.259-269.1948

Cited by 29 publications

(16 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Other strains similarly tested did not appear to produce different amounts of streptomycin in their sensitive and resistant phases. This is in agreement with the findings of Waksman et al (1948). Since this problem was encountered, all parent strains for irradiation have been phage-resistant.…”

Section: ]supporting

confidence: 92%

See 1 more Smart Citation

Improvement in Streptomycin-Producing Strains of Streptomyces Griseus by Ultraviolet and X-Ray Energy

Savage

1949

J Bacteriol

View full text Add to dashboard Cite

Section: ]supporting

confidence: 92%

“…The strain of S. griseus used as a parent in this entire study was the Waksman no.4 strain obtained from Dr. Selman A. Waksman in late 1944. This, according to Waksman et al (1948), has been assigned the Rutgers culture collection number 3496.…”

Section: Methodsmentioning

confidence: 99%

Improvement in Streptomycin-Producing Strains of Streptomyces Griseus by Ultraviolet and X-Ray Energy

Savage

1949

J Bacteriol

View full text Add to dashboard Cite

“…When yields of hydroxystreptomycin in shaken-flasks containing these inocula were compared with those from inocula containing no hydroxystreptomycin, little or no difference was found. This finding confirms that of Waksman et al (1948). A marked difference was noted in the ability of S. griseus and S. griseocarneus to develop from partially autolyzed, shaken-flask cultures.…”

Section: ]supporting

confidence: 86%

Studies on Streptomyces Griseocarneus and the Production of Hydroxystreptomycin

et al. 1951

View full text Add to dashboard Cite

The production of streptomycin is limited mostly to a few strains of Streptomyces griseus (Schatz, Bugie, and Waksman, 1944; Waksman, Reilly, and Johnstone, 1946; Carvajal, 1946a and b) and to Streptomyces bikiniensis (Johnstone and Waksman, 1948). Trussell, Fulton, and Grant (1947) examined a strain of Streptomyces which appeared to produce both streptomycin and streptothricin. Although this organism resembled Streptomyces lavendulae, it possessed morphological and biochemical characteristics that differentiated it from the described species. More recently, Benedict et al. (1950) reported that a strain of Streptomyces griseocarneus nov. sp. produced a closely related member of the streptomycin series, hydroxystreptomycin, which differed from streptomycin only in having a hydroxymethyl group instead of a methyl group in the streptose portion of the molecule. From a strain of Streptomyces similar to, but not identical with, S. griseocarneus, Grundy et al. (1950) isolated and characterized an antibiotic identical with hydroxystreptomycin. The purpose of this paper is (1) to provide a detailed morphological and physiological description of S. griseocarneus as stipulated by Benedict et al. (1950), and (2) to report studies on the production of hydroxystreptomycin by this organism in laboratory and pilot-plant scale fermentation and to consider other factors encountered in this work. EXPERIMENTAL METHODS AND RESULTS

show abstract

“…2 The trade-mark of American Cyanamid Company for the antibiotic chlortetracycline is Aureomycin. biological activity and are produced simultaneously by the same organism are illustrated by spinulosin, fumigatin, and gliotoxin (Menzel et al, 1944); actidione, grisein, and streptomycin (Waksman et al, 1948;Whiffen, 1948); rimocidin and oxytetracycline (Davisson et al, 1951); fradicin and neomycin (Waksman, 1953); chlortetracycline and an antifungal compound (Duggar et al, 1954); and fungicidin and an actidione-like antibiotic (Hazen and Brown, 1951).…”

mentioning

confidence: 99%